Amneal Pharmaceuticals of New York, LLC recalls Lorazepam Oral Concentrate, USP, 2 mg/mL, 30 mL bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Branchburg, NJ…
- Recall date
- August 3, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0120-2018
- FDA classification
- Class I
- Brand / firm
- Amneal Pharmaceuticals of New York, LLC
- Sold / distributed
- Nationwide
Why it was recalled
Defective Delivery System: the dropper measurement markings may be reversed, shifted or missing.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Lorazepam Oral Concentrate, USP, 2 mg/mL, 30 mL bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Branchburg, NJ 08876. Distributed by: Amneal Pharmaceuticals, Glasgow, KY 42141. NDC 65162-687-84
Get recall alerts
Free email alert whenever Amneal Pharmaceuticals of New York, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Amneal Pharmaceuticals of New York, LLC